The potential mechanism of these ARGs were diverse; for example, CDH2, also known as N‐cadherin, could confer anoikis resistance in esophageal carcinoma with high intracellular PKCK2 activity.19 This evidence concerns the gene CDH2 and carcinoma of esophagus.